Get startedLog in
    Picture of Recursion Pharmaceuticals logo

    RXRX — Recursion Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    All News

    Recursion's blood vessel disorder drug meets main goal in mid-stage study

    Picture of Recursion Pharmaceuticals logoRecursion Pharmaceuticals
    03/09/2024 13:08
    Sept 3 (Reuters) - Recursion Pharmaceuticals  RXRX.O 
said on Tuesday its experimental drug to treat a condition that
causes blood vessel malformation met the main goal of safety and
tolerability in a mid-stage study. 

 (Reporting by Mariam Sunny in Bengaluru; Editing by Alan
Barona)
 ((Mariam.ESunny@thomsonreuters.com))

    Recent news on Recursion Pharmaceuticals

    See all news